BRPI0416913A - peptìdeo de eritropoietina, método de fabricação da eritropoietina peguilada, uso do peptìdeo e formulação farmacêutica - Google Patents
peptìdeo de eritropoietina, método de fabricação da eritropoietina peguilada, uso do peptìdeo e formulação farmacêuticaInfo
- Publication number
- BRPI0416913A BRPI0416913A BRPI0416913-1A BRPI0416913A BRPI0416913A BR PI0416913 A BRPI0416913 A BR PI0416913A BR PI0416913 A BRPI0416913 A BR PI0416913A BR PI0416913 A BRPI0416913 A BR PI0416913A
- Authority
- BR
- Brazil
- Prior art keywords
- peptide
- erythropoietin
- conjugates
- pharmaceutical formulation
- manufacturing
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52498903P | 2003-11-24 | 2003-11-24 | |
US53938704P | 2004-01-26 | 2004-01-26 | |
US55550404P | 2004-03-22 | 2004-03-22 | |
US59057304P | 2004-07-23 | 2004-07-23 | |
US59274404P | 2004-07-29 | 2004-07-29 | |
US61551804P | 2004-09-29 | 2004-09-29 | |
US62338704P | 2004-10-29 | 2004-10-29 | |
PCT/US2004/039712 WO2005051327A2 (en) | 2003-11-24 | 2004-11-24 | Glycopegylated erythropoietin |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0416913A true BRPI0416913A (pt) | 2007-01-16 |
Family
ID=37621938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416913-1A BRPI0416913A (pt) | 2003-11-24 | 2004-11-24 | peptìdeo de eritropoietina, método de fabricação da eritropoietina peguilada, uso do peptìdeo e formulação farmacêutica |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0416913A (pt) |
-
2004
- 2004-11-24 BR BRPI0416913-1A patent/BRPI0416913A/pt not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0417341A (pt) | fator ix glicopeguilado | |
BRPI0614839A2 (pt) | fator vii e fator viia glicopeguilados | |
BRPI0417342A (pt) | fator estimulante de colÈnia de granulócitos glicopeguilado | |
WO2005051327A3 (en) | Glycopegylated erythropoietin | |
WO2006127910A3 (en) | Glycopegylated erythropoietin formulations | |
FI93227C (fi) | Hiilihydraattiyhdisteen käyttö in vitro viruspartikkelien tai viruksen pintakomponenttien valmistukseen tai eristämiseen | |
WO2006127896A3 (en) | Glycopegylated factor ix | |
WO2006031811A3 (en) | Glycopegylated interferon alpha | |
BRPI0010612B8 (pt) | vacinas | |
BR9913446A (pt) | Produtos de aglicona e métodos de uso | |
WO2006074467A3 (en) | Glycopegylated granulocyte colony stimulating factor | |
WO2005056760A3 (en) | Glycopegylated follicle stimulating hormone | |
BR9611533A (pt) | Lipopoliamina composição e utilização e processo de preparação de uma lipopoliamina | |
BRPI0507026A (pt) | proteìnas de fusão de albumina | |
BRPI0513959A (pt) | anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos | |
ES2328474T3 (es) | Preparacion de iscom y su utilizacion. | |
BRPI0612654B8 (pt) | método para conjugar um sacarídeo a uma proteína, e, conjugado sacarídeo-proteína | |
WO2003037172A3 (en) | Endothelial-cell binding peptides for diagnosis and therapy | |
AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
ATE369878T1 (de) | Träger-pharmaka-konjugate | |
BR0213303A (pt) | Proteìnas de ligação de alvejamento direto | |
WO2007008463A3 (en) | Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment | |
WO2008084411A3 (en) | Modified saccharides | |
WO2005030258A3 (en) | Small molecule compositions and methods for increasing drug efficiency using compositions thereof | |
WO2006116475A3 (en) | Immunostimulatory compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: BIOGENERIX AG (DE) Free format text: TRANSFERIDO DE: NEOSE TECHNOLOGIES, INC. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: BIOGENERIX AG (DE) |
|
B25D | Requested change of name of applicant approved |
Owner name: BIOGENERIX GMBH (DE) |
|
B25A | Requested transfer of rights approved |
Owner name: RATIOPHARM GMBH (DE) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 14A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |